Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11969499
Hydrogel delivery of sting immunotherapy for treatment cancer
granted patentUS 11969511
Methods and compositions for antimicrobial treatment
granted patentUS 11970521
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
granted patentUS 11971410
Methods of classifying response to immunotherapy for cancer
granted patentUS 11969401
Compositions and methods for treating or limiting development of age-related macular degen
granted patentUS 11969522
Use of immune modulators to improve nerve regeneration
granted patentUS 11963945
Ozonides for treating or preventing virus infections
granted patentUS 11958849
GLS1 inhibitors for treating disease
granted patentUS 11951118
Preparation of preliposomal annamycin lyophilizate
granted patentUS 11951227
Nanofiber structures and methods of use thereof
granted patentUS 11952379
Small molecule modulators of PAR2 and uses thereof
granted patentUS 11952330
Antibiotic ammonium compounds and methods for the treatment of bacterial infections
granted patentUS 11946065
Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-opti
granted patentUS 11939370
Pan-ebola virus neutralizing human antibodies and methods of use therefor
granted patentUS 11931460
Aminoglycoside antibiotic-derived microbead-encapsulated spheroids and methods of making a
granted patentUS 11925642
Regulation of eIF4E activity for migraine therapy
granted patentUS 11925654
Esters of 2-deoxy-monosaccharides with anti proliferative activity
granted patentUS 11926824
miRNA biogenesis in exosomes for diagnosis and therapy
granted patentUS 11918642
HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting H
granted patentUS 11919927
Prefusion-stabilized hMPV F proteins
granted patentUS 11919937
T cell receptors for immunotherapy
granted patentUS 11920139
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogeni
granted patentUS 11918646
Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
granted patentUS 11912762
Method of treating osteoarthritis by administering an anti-connexin 43 antibody
granted